GW PHARMACEUTICALS PLC: 8-K Report
8-K...…
Börse:
218,572$
-0,11%
Echtzeit-Aktienkurs GW Pharmaceuticals Plc
Bid:
217,973$
Ask:
219,171$
Nachrichten zur GW Pharmaceuticals Plc Aktie
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting
EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies...…
Insiderhandel: Chief Legal Officer verkauft Aktien von GW Pharmaceuticals im Wert von 152.208$
Snyder, Douglas B. - Vorstand - Tag der Transaktion: 2021-03-26...…
Insiderhandel: Aufsichtsrat verkauft Aktien von GW Pharmaceuticals im Wert von 55.386$
Knappertz, Volker - Aufsichtsrat - Tag der Transaktion: 2021-03-26...…
GW PHARMACEUTICALS PLC: 8-K Report
8-K...…
Insiderhandel: Aufsichtsrat verkauft Aktien von GW Pharmaceuticals im Wert von 72.159$
Brown, Cabot - Aufsichtsrat - Tag der Transaktion: 2021-03-18...…
Why GW Pharmaceuticals Stock Rocketed 40.5% in February
The cannabis-based pharmaceutical company agreed to be acquired....…
GW PHARMACEUTICALS PLC: 10-K Report
10-K...…
GW Pharma get European nod on expanded label for Epidyolex
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated with Tuberous Sclerosis Complex
– If approved by the European Commission (EC), the label for EPIDYOLEX® will expand to include a third indication in…
The GW Pharma and Parallel Transactions: Where Does the Future of Cannabis go From Here?
This month, two groundbreaking deals in cannabis were announced — the acquisition of GW Pharmaceuticals by Jazz Pharmaceuticals and the…
Northern Leaf: European cannabis first mover now has a clear line of sight to a London Stock Exchange listing
The $7.2bn takeover of GW Pharma has defined what success looks like for cannabis companies on this side of the…
GW Pharmaceuticals Beats on Revenue, Bottom Line for Q4
The companys net loss was far narrower than many expected....…
Mid-Day Market Update: Gold Slides Further, GW Pharma Reports Topline Growth
Midway through trading Tuesday, the Dow traded higher by 0.14% to 31,502.73, while the NASDAQ fell 0.47% to 14,029.30 and…
GW Pharmaceuticals: Q4 Earnings Insights
Shares of GW Pharmaceuticals (NASDAQ:GWPH) fell 0.2% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share were…
GW PHARMACEUTICALS PLC: 8-K Report
8-K...…
GW Pharmaceuticals EPS misses by $0.02, beats on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of GW Pharmaceuticals plc - GWPH
NEW YORK , Feb. 12, 2021 /PRNewswire/ -- …
Jazz Pharma will GW Pharma kaufen: Iren zahlen 7,2 Milliarden Dollar für Cannabis-Firma
Ein M&A-Deal im Milliardenformat rückt den Markt für Arzneimittel auf Basis von Cannabis in den Fokus: Das Geschäft fristet in…
GF Global Cannabis Opportunity Fund: M&A Paukenschlag im Biotechsektor: GW Pharmaceuticals soll für 7,2 Mrd.$ geschluckt werden.
Die Aktie ist die größte Einzelposition im GF Global Cannabis Opportunity Fund. Das irische Pharmaunternehmen Jazz Pharmaceuticals gab am 03.02.21 bekannt,…
Jazz Pharmaceuticals: GW Pharmaceuticals Acquisition Makes Sense
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Willow Biosciences is set to benefit from Jazz Pharmaceuticals acquisition of GW Pharmaceuticals
Jazz Pharmaceuticals Plcs (NASDAQ:JAZZ) recently-announced deal to acquire cannabis-derived drug maker GW Pharmaceuticals Plc (NASDAQ:GWPH) for US$7.2 billion in cash and…
Cardiol CEO sees bright future for pharmaceutically produced cannabidiol after blockbuster Jazz-GW Pharmaceutical deal
A blockbuster deal announced earlier this week could be a sign of a bright future for cannabidiol-oriented pharmaceutical companies. On…
Cannabis ETFs Spike on Jazz-GW Pharma Deal
Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that…
Cannabis Report: Große Übernahme im Sektor - Jazz Pharma kauft GW Pharmaceuticals
Die Wahlen in den USA haben dem Cannabissektor massiven Schwung verlieren. Die Erwartungen der Marktteilnehmer sind immens, was die…
Jazz Pharmaceuticals to buy cannabis pioneer GW Pharmaceuticals for US$7.2bn
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) has agreed to acquire pioneering cannabis firm GW Pharmaceuticals plc (NASDAQ:GWPH) for US$7.2bn (£5.2bn) or US$220…
GW PHARMACEUTICALS PLC: 8-K Report
8-K...…
SHAREHOLDER ALERT: WeissLaw LLP Investigates GW Pharmaceuticals plc
NEW YORK , Feb. 3, 2021 /PRNewswire/ -- WeissLaw LLP …
Jazz Pharma raised at Piper Sandler on GW Pharma deal
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Mid-Afternoon Market Update: Dow Gains 75 Points; GW Pharmaceuticals Shares Jump On Acquisition News
Toward the end of trading Wednesday, the Dow traded up 0.25% to 30,763 while the NASDAQ rose 0.5% to 13,680.71.…
Aphria, Cannabis Stocks Soar as Jazz Pharma to Buy GW Pharma
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Jazz Pharma to buy GW Pharma for $7.2 billion, adding cannabis-based drug to portfolio
Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal…
How to Trade Jazz Pharmaceuticals After Its Acquisition of GW Pharma
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Jazz Pharmaceuticals to Acquire Cannabis Drug Company
The deal to buy GW Pharmaceuticals creates a leader in neuroscience....…
Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits
Cannabis stocks rallied anew on Wednesday, spurred on by news of a $7 billion deal for the first company to…
GW Pharmaceuticals: Grund ist ein Übernahmedeal! Aktienanalyse
Kulmbach (www.aktiencheck.de) - GW Pharmaceuticals-Aktienanalyse von "Der Aktionär":
Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die GW…
Jazz Pharma to buy GW Pharma for $7.2 bln, adding cannabis-based drug to portfolio
Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal…
In Jazz acquisition of GW Pharma, Epidiolex is tip of cannabinoid iceberg
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Rallye bei Canopy Growth, Aphria, GW Pharma & Co – Cannabis-Index mit neuem Allzeithoch
Die Aktien der Cannabis-Unternehmen sind derzeit kaum mehr zu bremsen. Am heutigen Mittwoch geht es bei den Papieren erneut kräftig…
Jazz Pharmaceuticals to Buy GW Pharma for $6.7 Billion
The deal, combining two neuroscience drugmakers, marks a bet by Jazz on the long-term prospects for cannabis-based therapies....…
Why Aurora Cannabis, Cronos And Tilray Are Trading Higher Today
The shares of several cannabis companies are trading higher on Wednesday following the announcement of the Jazz Pharma deal for…
Jazz Pharma adds cannabis-based drug in $7.2 billion deal for GW Pharma
Jazz Pharmaceuticals Plc said on Wednesday it would buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal to bolster…
Why GW Pharmaceuticals Stock Is Skyrocketing Today
Investors cheered an unexpected acquisition of the cannabinoid-focused biotech....…
PAOG Highlights Its Own Cannabis Pharma Tech As GW Pharma Valued At $7.2 B
SANDUSKY, Ohio , Feb. 3, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today highlighted…
Tyme Technologies, GW Pharmaceuticals leads healthcare gainers; Vaxart, Moleculin Biotech among major losers
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cannabis-Derived Drug Maker GW Pharma Acquired by Jazz Pharma for $7.2 Billion
Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Thinking about trading options or stock in GW Pharmaceuticals, Bristol-Myers Squibb, Aurora Cannabis, Alibaba, or Workday?
NEW YORK , Feb. 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GWPH,…
Zogenix jumps on positive read through from GW Pharma/Jazz deal
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Jazz Pharmaceuticals buys GW Pharma for $7.2 billion
Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share. CNBC's Becky Quick…